CereVasc

Leadership in Cerebrospinal Fluid (CSF) Management, Access, and Therapy

Boston, United States · Founded 2014 · $278.9M raised

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$278.9M
Last Round
$85.0M Series CJun 2026
Rounds
6

About

CereVasc develops the investigational eShunt System, a minimally invasive treatment for communicating hydrocephalus and normal pressure hydrocephalus. Its endovascularly implantable cerebrospinal fluid shunt uses a percutaneous transvenous-transdural approach intended to treat patients without invasive surgery. The company is evaluating the system against conventional VP shunts in the randomized STRIDE pivotal trial to support a future FDA premarket approval submission.

Summary

CereVasc is a Healthcare company based in Boston, United States, founded in 2014. It has raised $278.9M in total across 6 rounds, most recently a $85.0M Series C round in Jun 2026. Investors include Bain Capital Life Sciences, Perceptive Advisors and Covidien Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJun 2026
$85.0M

Sign up to see all 6 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CereVasc on Indexed.vc
<a href="https://indexed.vc/companies/cerevasc"><img src="https://indexed.vc/api/badge/company/cerevasc" alt="CereVasc on Indexed.vc" width="260" height="76" /></a>